Does a diagnosis of CKD increase the relative risk of mortality and life-years lost more significantly in younger adults compared to older adults when matched against peers without CKD?
Younger adults (aged 21-35) with CKD face a nearly 5-fold higher relative risk of mortality compared to age-matched peers without CKD, representing the greatest reduction in lifespan across the age spectrum.
Key Points Limited data exist to inform younger persons with CKD how their risk for mortality compares with equivalently aged individuals without CKD. Compared with the general population without CKD, the age-stratified risk for mortality was highest in younger individuals with CKD. From a lifetime perspective, the estimated reduction of lifespan secondary to CKD was greatest at younger ages. Background Younger individuals living with CKD face a lifetime at risk for complications and mortality. Limited data exist to inform individual patients with CKD across the lifespan how their risk for mortality compares with equivalently aged individuals without CKD, particularly at younger ages. The objective of this study was to provide age-specific contexts to the risk of mortality associated with a diagnosis of CKD. Methods We created a pooled study cohort using participants with CKD enrolled in the Chronic Renal Insufficiency Cohort along with participants aged 21–75 years included in the 1999–2008 National Health and Nutrition Examination Survey surveys. Age-stratified mortality rates, along with unadjusted and adjusted hazard ratios (HRs) for mortality, were generated to compare differences between those with and without CKD. The mean life-years lost (LYL) relating to CKD was calculated using Centers for Disease Control and Prevention life tables. Results A total of 16,725 participants were included. Mortality rates were higher in those with CKD at all ages. The adjusted age-stratified HR for mortality in those with CKD versus without was highest in the 21–35 years strata (HR 95% confidence interval (CI), 4.9 2.8 to 8.6)) and lowest in the 65–75 years strata (HR 95% CI, 2.0 1.7 to 2.3). The mean LYL secondary to CKD was inversely related with increasing age. Conclusions Compared with age-matched peers without CKD, the age-stratified risk for mortality and LYL associated with a diagnosis of CKD is highest in younger individuals. Further research is needed to elucidate the societal and personal costs of premature mortality associated with CKD in young adults.
Kula et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: